Koers TaiGen Biopharmaceuticals Holdings Limited
Aandelen
4157
KYG866171005
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,45 TWD | 0,00% | +5,10% | +1,64% |
Omzet 2022 | 36,23 mln. 1,13 mln. 1,05 mln. | Omzet 2023 | 123 mln. 3,85 mln. 3,57 mln. | Marktkapitalisatie | 10,91 mld. 341 mln. 316 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -237 mln. -7,41 mln. -6,87 mln. | Nettowinst (verlies) 2023 | 137 mln. 4,28 mln. 3,97 mln. | EV/omzet 2022 | 294 x |
Nettoliquiditeiten 2022 | 860 mln. 26,88 mln. 24,93 mln. | Nettoliquiditeiten 2023 | 963 mln. 30,11 mln. 27,92 mln. | EV/omzet 2023 | 80,8 x |
K/w-verhouding 2022 |
-48,5
x | K/w-verhouding 2023 |
80
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 50% |
1 week | +5,10% | ||
Lopende maand | +2,32% | ||
1 maand | +3,00% | ||
3 maanden | +2,32% | ||
6 maanden | +6,92% | ||
Lopend jaar | +1,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Philip Huang
CEO | Chief Executive Officer | - | 17-12-18 |
Richard Lue
DFI | Director of Finance/CFO | - | 01-04-16 |
Ming-Chu Hsu
BRD | Director/Board Member | - | 01-04-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shou-Chuan Ho
BRD | Director/Board Member | - | 29-04-13 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 01-04-13 |
Sheng Fu Yu
BRD | Director/Board Member | 79 | 12-06-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 4 M€ | -4,41% | - | |
0.00% | 36 M€ | +4,92% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 15,45 | 0,00% | 2 547 128 |
27-03-24 | 15,45 | +0,65% | 3 140 431 |
26-03-24 | 15,35 | -0,32% | 3 015 181 |
25-03-24 | 15,4 | +3,36% | 4 393 447 |
22-03-24 | 14,9 | +1,36% | 1 005 757 |
slotkoers Taipei Exchange, 28 maart 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+1,64% | 347 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |